+Compare
COO
Stock ticker: NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
15.45B

COO Cooper Companies (The) Forecast, Technical & Fundamental Analysis

a maker of medical devices

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for COO with price predictions
08:00 PM EDT Oct 02, 2023

COO in -2.34% downward trend, falling for three consecutive days on October 02, 2023

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where COO declined for three days, in of 276 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 01, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on COO as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for COO turned negative on September 01, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

The Aroon Indicator for COO entered a downward trend on October 03, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 20 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where COO advanced for three days, in of 336 cases, the price rose further within the following month. The odds of a continued upward trend are .

COO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. COO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.052) is normal, around the industry mean (24.901). P/E Ratio (56.497) is within average values for comparable stocks, (79.018). Projected Growth (PEG Ratio) (2.123) is also within normal values, averaging (6.345). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (4.417) is also within normal values, averaging (58.146).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.24B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -2%. For the same Industry, the average monthly price growth was -9%, and the average quarterly price growth was -11%. IMTH experienced the highest price growth at 120%, while SDC experienced the biggest fall at -82%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -27%. For the same stocks of the Industry, the average monthly volume growth was 39% and the average quarterly volume growth was 86%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 67
SMR Rating: 84
Profit Risk Rating: 89
Seasonality Score: 2 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

COO is expected to report earnings to rise 4.18% to $3.49 per share on December 07

Cooper Companies (The) COO Stock Earnings Reports
Q4'23
Est.
$3.49
Q3'23
Beat
by $0.01
Q2'23
Beat
by $0.06
Q1'23
Beat
by $0.21
Q4'22
Missed
by $0.38
The last earnings report on August 30 showed earnings per share of $3.35, beating the estimate of $3.34. With 293.96K shares outstanding, the current market capitalization sits at 15.45B.
A.I.Advisor
published Dividends

COO paid dividends on August 11, 2023

Cooper Companies (The) COO Stock Dividends
А dividend of $0.03 per share was paid with a record date of August 11, 2023, and an ex-dividend date of July 26, 2023. Read more...
A.I. Advisor
published General Information

General Information

a maker of medical devices

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
6101 Bollinger Canyon Road
Phone
+1 925 460-3600
Employees
14000
Web
https://www.coopercos.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CFB9.91-0.05
-0.45%
CrossFirst Bankshares
FONR14.99-0.21
-1.39%
Fonar Corp
FFIV159.51-2.45
-1.51%
F5, Inc.
RAMP28.73-0.80
-2.71%
LiveRamp Holdings
PRFX3.10-0.23
-6.91%
PainReform Ltd

COO and

Correlation & Price change

A.I.dvisor indicates that over the last year, COO has been closely correlated with RVTY. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if COO jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COO
1D Price
Change %
COO100%
+0.32%
RVTY - COO
69%
Closely correlated
-0.54%
IDXX - COO
66%
Closely correlated
-1.33%
SYK - COO
63%
Loosely correlated
-2.91%
ALC - COO
63%
Loosely correlated
-1.63%
CNMD - COO
62%
Loosely correlated
+0.69%
More

Groups containing COO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COO
1D Price
Change %
COO100%
+0.32%
COO
(undefined stocks)
85%
Closely correlated
-0.51%
medical research
(undefined stocks)
78%
Closely correlated
-1.22%
medical service
(undefined stocks)
77%
Closely correlated
-1.24%
medical devices
(undefined stocks)
75%
Closely correlated
-1.17%
Medical Specialties
(undefined stocks)
75%
Closely correlated
-1.44%
More